Archives
-
HATU for Peptide Coupling and Inhibitor Synthesis
2026-09-29
HATU combines rapid carboxylic acid activation with practical control over amide and ester formation, making it useful for peptide synthesis chemistry and medicinal chemistry libraries. This guide connects bench-scale coupling decisions with the structure-guided IRAP inhibitor work reported in the reference study, while keeping synthetic performance separate from biological validation.
-
CAF–ANGPTL4–IQGAP1 Axis in Prostate Cancer
2026-09-29
This study identifies a paracrine CAF–ANGPTL4–IQGAP1 pathway that reprograms prostate cancer cells toward mitochondrial biogenesis and oxidative phosphorylation, reducing chemotherapy sensitivity. Its integrated proteomic, metabolomic, biochemical, and pharmacologic approach highlights tumor–stroma signaling as a potential target for improving docetaxel response.
-
Cycloheximide in Hypoxia–Apoptosis Research
2026-09-28
Cycloheximide is a protein biosynthesis inhibitor that can clarify how translational capacity shapes hypoxia-associated apoptosis. This article connects ribosomal elongation blockade with HIF-1α–Septin4 biology and shows how to interpret protein turnover and caspase readouts without overstating causality.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-09-28
This HRP-labeled secondary antibody detects mouse IgG primary antibodies in workflows such as Western blotting, ELISA, IHC, and ICC, where enzyme-based signal development is required. It is not a substitute for a primary antibody and is not intended to detect non-mouse primary antibodies or to serve as a live-cell sorting reagent.
-
Tricine-SDS-PAGE Gel Preparation Kit Workflow
2026-09-27
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed to improve separation of low-molecular-weight proteins and peptides, particularly in the 1–10 kDa range. It is intended for research electrophoresis workflows, including appropriately configured denaturing or non-denaturing applications, and is not for diagnostic or medical use.
-
2,2,2-Trichloroethanol in Translational Protein Analysis
2026-09-26
Explore how 2,2,2-Trichloroethanol can support protein-level checks in research workflows—and why those checks answer different questions from dopamine-transporter PET. A critical reading of a Parkinson’s cell-therapy study shows how to connect molecular biology research with in vivo evidence without conflating the methods.
-
Phosphatase Inhibitor Cocktail 1 for Signaling
2026-09-25
Preserve phosphorylation during cell and tissue lysis with a DMSO-based cocktail formulated to inhibit alkaline and serine/threonine phosphatases. See how to integrate it into Western blot, co-immunoprecipitation, and phosphoproteomic workflows—and how to interpret those assays alongside transcriptional findings in HPV16-positive cancer research.
-
Phosphatase Inhibitor Cocktail 1 for CRC Signaling
2026-09-25
Preserve phosphoprotein readouts when testing colorectal cancer signaling, from p-AKT and p-mTOR Western blots to phosphoproteomic workflows. This practical guide shows how to add a 100X inhibitor stock to lysis steps, control DMSO, and troubleshoot results without implying that the featured CRC study used this reagent.
-
α-Bungarotoxin for Nicotinic Receptor Blockade
2026-09-24
Use α-Bungarotoxin to test whether α7 nicotinic acetylcholine receptor signaling is required for a cellular response—not merely associated with it. A recent placental ischemia study illustrates how antagonist reversal can connect cholinergic signaling to necroptosis, inflammation, and trophoblast behavior, while offering a practical framework for controlled follow-up experiments.
-
SNS-032: Interpreting CDK Inhibition Across Cell Systems
2026-09-24
SNS-032 (BMS-387032) inhibits CDK2, CDK7, and CDK9, but its effects must be interpreted across phosphorylation, protein abundance, and cell-state readouts. This article connects cancer-research workflows with a 2026 SARS-CoV-2 host-factor study while clearly distinguishing its CDK9 inhibitor from SNS-032.
-
PDGF-BB Assays for Vascular Remodeling Research
2026-09-23
Use murine recombinant PDGF-BB as a defined mitogenic stimulus to benchmark smooth muscle cell proliferation alongside hypoxia-driven pulmonary vascular remodeling. This workflow pairs practical dose-finding and handling guidance with clear limits: PDGF-BB is an experimental comparator, not a substitute for the ALDOB–DRP1 mechanism described in the reference study.
-
Protein A/G Magnetic Co-IP/IP Kit for AP2-M
2026-09-23
Learn how the Protein A/G Magnetic Co-IP/IP Kit can complement chromatin, transcriptomic, and proteomic studies of Babesia AP2-M. This article develops a parasite-focused strategy for testing physical protein complexes without confusing interaction evidence with DNA-binding or expression data.
-
Trypsin Workflows for Cell and Protein Research
2026-09-22
Translate the predictable cleavage of this serine protease into practical protein-digestion, cell-handling, wound-healing, and membrane-fusion workflows. This guide combines executable starting conditions with troubleshooting and a carefully bounded connection to advanced NIR-II tumor-therapy research.
-
Phosphatase Inhibitor Cocktail 1: Assay Logic
2026-09-22
Phosphatase Inhibitor Cocktail 1 is more than a routine lysis additive: it is an endpoint-control tool for protein phosphorylation preservation. This guide connects its selective inhibitor chemistry with chromatin-focused research and practical decisions in phosphoproteomic analysis, Western blotting, and signaling assays.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-09-21
The reference study introduces metal-free carbon dots whose nanozyme activity is reversibly controlled by pyrophosphate, enabling a colorimetric alkaline phosphatase assay without metal-ion cofactors. Michaelis–Menten analysis shows that pyrophosphate inhibits the carbon-dot catalyst at a site distinct from its catalytic site, supporting an analytical range of 0.010–0.200 U/L and a detection limit of 0.009 U/L.